- Home
- ARCT vs EU Comparison
ARCT vs EU Comparison
Compare ARCT & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- EU
- Stock Information
- Founded
- ARCT 2013
- EU 2009
- Country
- ARCT United States
- EU United States
- Employees
- ARCT N/A
- EU N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- ARCT Health Care
- EU Basic Materials
- Exchange
- ARCT Nasdaq
- EU Nasdaq
- Market Cap
- ARCT 487.0M
- EU 615.4M
- IPO Year
- ARCT N/A
- EU N/A
- Fundamental
- Price
- ARCT $16.79
- EU $3.32
- Analyst Decision
- ARCT Strong Buy
- EU Strong Buy
- Analyst Count
- ARCT 7
- EU 2
- Target Price
- ARCT $65.00
- EU $6.50
- AVG Volume (30 Days)
- ARCT 400.9K
- EU 1.5M
- Earning Date
- ARCT 03-06-2025
- EU 11-14-2024
- Dividend Yield
- ARCT N/A
- EU N/A
- EPS Growth
- ARCT N/A
- EU N/A
- EPS
- ARCT N/A
- EU N/A
- Revenue
- ARCT $160,399,000.00
- EU $44,972,063.00
- Revenue This Year
- ARCT $7.33
- EU N/A
- Revenue Next Year
- ARCT $4.71
- EU $65.28
- P/E Ratio
- ARCT N/A
- EU N/A
- Revenue Growth
- ARCT N/A
- EU N/A
- 52 Week Low
- ARCT $14.30
- EU $3.02
- 52 Week High
- ARCT $45.00
- EU $5.05
- Technical
- Relative Strength Index (RSI)
- ARCT 46.15
- EU 43.40
- Support Level
- ARCT $16.07
- EU $3.26
- Resistance Level
- ARCT $17.95
- EU $3.46
- Average True Range (ATR)
- ARCT 1.36
- EU 0.17
- MACD
- ARCT -0.07
- EU -0.01
- Stochastic Oscillator
- ARCT 14.86
- EU 14.20
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.